Acting FDA Commissioner Lester Crawford to Deliver Keynote at BIO-Windhover Partnering Conference
WASHINGTON, D.C. (April 13, 2005) -- Lester Crawford, DVM, Ph.D., President George W. Bush’s nominee to serve as commissioner of the Food and Drug Administration (FDA), will deliver the keynote address Wednesday, April 27 at BIO-Windhover 2005. Now in its fourth year, BIO-Windhover is a premier U.S.-based partnering conference for senior pharmaceutical and biotechnology executives and business development professionals. The conference runs April 25-27, 2005 at the Ritz-Carlton in
Drawing on his current role as the agency’s acting commissioner, Dr. Crawford will discuss FDA's recent progress and future priorities, particularly as they relate to the bioscience industry.
“We’re thrilled that Dr. Crawford will be joining us at BIO-Windhover,” said Jim Greenwood, president of BIO. “His audience will be senior-level biotechnology and pharmaceutical executives and business development professionals who are unquestionably interested in evolving regulatory policies. Dr. Crawford has a wealth of knowledge gained from a remarkable career, and we look forward to his insightful comments.”
Dr. Crawford has played major roles in mandatory nutrition labeling, the formation of the World Trade Organization and the control of chemical and microbiological contaminants of food. He has been an advisor to the World Health Organization of the United Nations for much of his career.
Dr. Crawford previously served as deputy commissioner of FDA. He also was chair of the Department of Physiology-Pharmacology at the
Dr. Crawford received a DVM from
Attendees at BIO-Windhover 2005 will have an opportunity to meet one-on-one with other key decision makers, network with their peers and learn about the latest trends in deal making. Senior executives can move quickly from identifying prospective partners to meeting face-to-face using the BIO-Windhover partnering software. The conference is hosted by the Biotechnology Industry Organization (BIO) and Windhover Information Inc.
To register for this event and for information about the program, visit www.biowindhover.com. Registration is complimentary for credentialed members of the news media. Press interested in registering for this event should send an e-mail to biopartnering@bio.org.
Since 1989, Windhover Information Inc. has been providing superior analysis and commentary on health care business strategy, deal making, marketplace trends, and the world of medical start-ups. The expertise that its editorial and research staff have developed - now consulted and relied upon by the industry's top executives, consultants, bankers and investors--finds voice in its publications, leading-edge conferences, and integrated, highly searchable databases of transactions and commentary. Windhover's editorial goal: To clearly present objective, accurate, fundamentally valuable decision-making information. In May 2004, Windhover acquired the assets of Medtech Insight, LLC, making it the pre-eminent information services provider for medical device and diagnostics executives worldwide, as well as biotech and pharmaceutical leaders. Visit www.windhover.com for information on Windhover Information and its family of products and services. Windhover Information is based in
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the
###